| Code | CSB-RA795810A0HU |
| Size | US$210 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
| Application | Recommended Dilution |
|---|---|
| WB | 1:500-1:2000 |
| IHC | 1:50-1:200 |
TYRO3 is a receptor tyrosine kinase belonging to the TAM family, playing essential roles in cell survival, proliferation, and the regulation of innate immunity. This kinase participates in the clearance of apoptotic cells and has emerged as a significant focus in cancer research, where its overexpression has been linked to tumor progression and therapeutic resistance across multiple malignancies.
This recombinant monoclonal antibody, clone 8D8, offers researchers the reproducibility and consistency that comes with sequence-defined production. Unlike traditional hybridoma-derived antibodies, recombinant technology ensures that every lot performs identically, eliminating the variability that can compromise longitudinal studies or multi-site collaborations. The rabbit IgG format provides excellent sensitivity while the affinity-chromatography purification delivers a clean reagent suitable for demanding applications.
Validation studies confirm reliable performance in Western blot and immunohistochemistry workflows. In Western blot analysis of Jurkat whole cell lysate, the antibody detects TYRO3 at an observed molecular weight of approximately 128 kDa, which is higher than the predicted 97 kDa. This size difference is consistent with extensive post-translational glycosylation characteristic of receptor tyrosine kinases. Immunohistochemical staining in paraffin-embedded human cervical cancer tissue demonstrates clear visualization of TYRO3 expression, with optimal results achieved using citrate buffer antigen retrieval and overnight primary antibody incubation.
The antibody's validated performance across both biochemical and tissue-based applications makes it well-suited for researchers investigating TAM receptor biology, tumor microenvironment interactions, or therapeutic target validation in oncology programs.
There are currently no reviews for this product.